Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
Int. j. cardiovasc. sci. (Impr.) ; 32(2): 125-133, mar.-abr. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-989989

RESUMO

Although new studies and guidelines can be considered useful tools, it does not necessarily mean they are put into clinical practice. Objective: The aim of the current analysis was to assess the changes in primary percutaneous coronary intervention (PCI) and mortality in a tertiary university hospital in southern Brazil during a six-year period. Methods: We have included consecutive patients with ST-elevation myocardial infarction (STEMI) who underwent primary PCI between March 2011 and February 2017. Previous clinical history, characteristics of the procedure, and reperfusion strategies were collected. In-hospital, short and long-term mortalities were also evaluated. The significance level adopted for all tests was 5%. Results: There was an increase in the use of radial access in patients from 20.0% in 2011 to 62.7% in 2016 (ptrend < 0.0001). Moreover, thrombus aspiration decreased significantly from 66.7% in 2011 to less than 3.0% in 2016 (ptrend < 0.0001). In-hospital, short and long-term mortalities remained reasonably stable from 2011 to 2016 (ptrend > 0.05). However, a lower in-hospital mortality was observed in patients treated through radial access (p < 0.001). Cardiogenic shock occurred in 11.1%, without statistical differences in the period (ptrend = 0.39), while long-term mortality rate decreased from 80.0% in 2011 to 27.3% in 2016 in this patient group (ptrend = 0.29). Conclusions: During a 6-year follow-up period, primary PCI characteristics underwent important modifications. Radial access became widely used, with a decrease in mortality with the use of this route, while aspiration thrombectomy became a rare procedure. The incidence of cardiogenic shock remained stable, but has shown a reduction in its mortality


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Atenção Terciária à Saúde , Intervenção Coronária Percutânea/métodos , Infarto do Miocárdio/mortalidade , Choque Cardiogênico , Doença da Artéria Coronariana , Análise Estatística , Estudos Prospectivos , Fatores de Risco , Resultado do Tratamento , Acidente Vascular Cerebral , Diabetes Mellitus , Hipertensão
2.
Int. j. cardiovasc. sci. (Impr.) ; 31(5)set.-out. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-914718

RESUMO

Background: The SAMe-TT2R2 score was introduced to identify atrial fibrillation patients with a high risk of not achieving a good time in therapeutic range (TTR) during vitamin K antagonists (VKA) therapy. Objective: The aim of this study was to evaluate this score in venous thromboembolism (VTE) patients. Patients and methods: A retrospective cohort study of patients receiving care at the outpatient anticoagulation clinic of a tertiary care teaching hospital. Patients were classified as having low (score 0-1) or high risk (score ≥2) of not achieving a good TTR. The area under the ROC curve was calculated to assess the ability of the score to predict a TTR ≥ 65%. Adverse event-free survival curves according to the SAMe-TT2 R2 score were calculated by the Kaplan-Meier method and compared by the log-rank test. A p-value < 0.05 was considered statistically significant. Results: We investigated 111 patients during a median follow-up of 2.3 (0.7-6.4) years. Mean age was 54.1 ± 15.7 years and 71 (64.0%) were women. Low- and high-risk groups had similar mean TTR (51.9 vs. 49.6%; p = 0.593). The two groups did not differ significantly in the percentage of patients achieving a TTR ≥ 65% (35.6 vs. 25.8%; p =0.370). The c-statistic was 0.595 (p = 0.113) for TTR ≥ 65%. Adverse event-free survival during anticoagulation was also similar in both groups (p = 0.136).Conclusions: The SAMe-TT2R2 score does not seem to be a useful tool in oral anticoagulation decision-making for patients with VTE and should not be used in this setting


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Anticoagulantes , Técnicas de Apoio para a Decisão , Tromboembolia Venosa/complicações , Tromboembolia Venosa/fisiopatologia , Fibrilação Atrial , Doenças Cardiovasculares/mortalidade , Estudos de Coortes , Comorbidade , Infarto do Miocárdio/mortalidade , Análise Estatística , Acidente Vascular Cerebral
3.
Int. j. cardiovasc. sci. (Impr.) ; 31(1): f:26-l:32, jan.-mar. 2018. tab, graf
Artigo em Português | LILACS | ID: biblio-883664

RESUMO

Fundamento: Diferentes escores baseados em variáveis anatômicas e/ou clínicas têm sido desenvolvidos para estratificação de risco em pacientes submetidos à intervenção coronariana percutânea (ICP). Estudos comparando a capacidade desses modelos na predição de eventos cardíacos e cerebrovasculares adversos maiores (ECCAM) em pacientes submetidos à ICP primária são escassos. Objetivo: O objetivo desse estudo foi o de comparar os escores SYNTAX (SS), Clinical SYNTAX (CSS), ACEF e ACEF modificado (ACEF Mod ) na predição de ECCAM em pacientes com infarto agudo do miocárdico com supradesnivelamento do segmento ST (IAMCSST) submetidos à ICP primária. Métodos: Foram analisados 311 pacientes consecutivos com IAMCSST submetidos a ICP primária entre abril/2011 e dezembro/2015. As áreas sob a curva característica de operação do receptor (ROC) foram calculadas para avaliar a habilidade desses escores em predizer ECCAM. O nível de significância adotado em todos os testes foi de 5%. Resultados: Os pacientes apresentaram idade média de 60,2 ± 12,0 anos, 35,4% eram do sexo feminino e 22,5% eram diabéticos. A ocorrência de ECCAM foi observada em 23,8% dos participantes. A área sob a curva ROC foi 0,586 (p = 0,028) para ACEF, 0,616 (p = 0,003) para SS, 0,623 (p = 0,002) para ACEF Mod e 0,658 (p < 0,001) para CSS. Na análise multivariada, apenas SS (p = 0,011) e CSS (p = 0,002) foram preditores independentes de ECCAM. Conclusões: SS e CSS elevados foram preditores independentes de ECCAM. Em nossa coorte de pacientes com IAMCSST submetidos à ICP primária, o SS calculado à cineangiocoronariografia inicial mostrou-se uma ferramenta útil para predizer ECCAM


Background: Different scores based on anatomical and/or clinical features have been developed for risk stratification of patients undergoing percutaneous coronary intervention (PCI). Studies comparing the ability of these different models in predicting major adverse cardiac and cerebrovascular events (MACCE) in patients submitted to primary PCI are limited. Objectives: The aim of this study was to compare the ability of the scores SYNTAX (SS), Clinical SYNTAX (CSS), age, creatinine and ACEF, and modified ACEF (ACEF Mod ) to predict MACCE in patients with ST-elevation myocardial infarction (STEMI) submitted to primary PCI. Methods: We analyzed 311 consecutive patients with STEMI submitted to primary PCI between April/2011 and December/2015. The area under the ROC curve was calculated to evaluate the ability of these scores in predicting MACCE. P-values were considered significant at < 0.05. Results: Mean age of the patients was 60.2 ± 12.0 years, 35.4% were females, and 22.5% had diabetes. MACCE occurred in 23.8% of the patients. The area under the ROC curve was 0.586 (p = 0.028) for ACEF, 0.616 (p = 0.003) for SS, 0.623 (p = 0.002) for ACEF Mod , and 0.658 (p < 0.001) for CSS. In multivariate analysis, only high SS (p = 0.011) and CSS (p = 0.002) were independent predictors of MACCE. Conclusions: High SS and CSS were independent predictors of MACCE. In our cohort of STEMI patients undergoing primary PCI, pure anatomical SS calculated at the baseline coronary angiography was a useful tool to predict MACCE


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Intervenção Coronária Percutânea/métodos , Probabilidade , Fatores de Risco , Aspirina/administração & dosagem , Estudos de Coortes , Doença da Artéria Coronariana/complicações , Vasos Coronários , Heparina/administração & dosagem , Análise Multivariada , Infarto do Miocárdio , Valor Preditivo dos Testes , Curva ROC , Análise Estatística , Acidente Vascular Cerebral/complicações
4.
Cardiovasc Interv Ther ; 33(3): 224-231, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28540634

RESUMO

Contrast-induced acute kidney injury (CI-AKI) is a common event after percutaneous coronary intervention (PCI). Presently, the main strategy to avoid CI-AKI lies in saline hydration, since to date none pharmacologic prophylaxis proved beneficial. Our aim was to determine if a low complexity mortality risk model is able to predict CI-AKI in patients undergoing PCI after ST elevation myocardial infarction (STEMI). We have included patients with STEMI submitted to primary PCI in a tertiary hospital. The definition of CI-AKI was a raise of 0.3 mg/dL or 50% in post procedure (24-72 h) serum creatinine compared to baseline. Age, glomerular filtration and ejection fraction were used to calculate ACEF-MDRD score. We have included 347 patients with mean age of 60 years. In univariate analysis, age, diabetes, previous ASA use, Killip 3 or 4 at admission, ACEF-MDRD and Mehran scores were predictors of CI-AKI. After multivariate adjustment, only ACEF-MDRD score and diabetes remained CI-AKI predictors. Areas under the ROC curve of ACEF-MDRD and Mehran scores were 0.733 (0.68-0.78) and 0.649 (0.59-0.70), respectively. When we compared both scores with DeLong test ACEF-MDRDs AUC was greater than Mehran's (P = 0.03). An ACEF-MDRD score of 2.33 or lower has a negative predictive value of 92.6% for development of CI-AKI. ACEF-MDRD score is a user-friendly tool that has an excellent CI-AKI predictive accuracy in patients undergoing primary percutaneous coronary intervention. Moreover, a low ACEF-MDRD score has a very good negative predictive value for CI-AKI, which makes this complication unlikely in patients with an ACEF-MDRD score of <2.33.


Assuntos
Lesão Renal Aguda/induzido quimicamente , Meios de Contraste/efeitos adversos , Intervenção Coronária Percutânea/efeitos adversos , Medição de Risco/métodos , Infarto do Miocárdio com Supradesnível do Segmento ST/cirurgia , Lesão Renal Aguda/diagnóstico , Fatores Etários , Idoso , Brasil , Creatinina/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Intervenção Coronária Percutânea/métodos , Curva ROC , Sistema de Registros , Estudos Retrospectivos , Fatores de Risco , Volume Sistólico/fisiologia
5.
Braz J Cardiovasc Surg ; 32(5): 372-377, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29211216

RESUMO

INTRODUCTION: The outcomes of Jehovah's Witness (JW) patients submitted to open heart surgery may vary across countries and communities. The aim of this study was to describe the morbidity and mortality of JW patients undergoing cardiac surgery in a tertiary hospital center in Southern Brazil. METHODS: A case-control study was conducted including all JW patients submitted to cardiac surgery from 2008 to 2016. Three consecutive surgical non-JW controls were matched to each selected JW patient. The preoperative risk of death was estimated through the mean EuroSCORE II. RESULTS: We studied 16 JW patients with a mean age of 60.6±12.1 years. The non-JW group included 48 patients with a mean age of 63.3±11.1 years (P=0.416). Isolated coronary artery bypass graft surgery was the most frequent surgery performed in both groups. Median EuroSCORE II was 1.29 (IQR: 0.66-3.08) and 1.43 (IQR: 0.72-2.63), respectively (P=0.988). The mortality tended to be higher in JW patients (18.8% vs. 4.2%, P=0.095), and there was a higher difference between the predicted and observed mortality in JW patients compared with controls (4.1 and 18.8% vs. 2.1 and 4.2%). More JW patients needed hemodialysis in the postoperative period (20.0 vs. 2.1%, P=0.039). CONCLUSION: We showed a high rate of in-hospital mortality in JW patients submitted to cardiac surgery. The EuroSCORE II may underestimate the surgical risk in these patients.


Assuntos
Procedimentos Cirúrgicos Cardíacos/estatística & dados numéricos , Testemunhas de Jeová , Procedimentos Cirúrgicos Cardíacos/mortalidade , Estudos de Casos e Controles , Feminino , Mortalidade Hospitalar , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Centros de Atenção Terciária , Resultado do Tratamento , Recusa do Paciente ao Tratamento
6.
Int. j. cardiovasc. sci. (Impr.) ; 30(6): f:517-l:525, Nov.-Dez. 2017. tab, graf
Artigo em Português | LILACS | ID: biblio-876067

RESUMO

Fundamento: O escore HAS-BLED foi desenvolvido para avaliar o risco em um ano de sangramento maior em pacientes com fibrilação atrial (FA) anticoagulados com antagonistas da vitamina K (AVK). Objetivo: O objetivo deste estudo foi avaliar a capacidade do escore HAS-BLED e de seus componentes em predizer sangramento maior em pacientes atendidos em um ambulatório de anticoagulação de um hospital terciário. Métodos: Foi realizado um estudo coorte retrospectivo com pacientes com FA tratados com AVK. Análise de regressão logística foi realizada para avaliar a capacidade de cada componente do escore em predizer sangramento maior. O nível de significância adotado em todos os testes foi de 5%. Resultados: Foram estudados 263 pacientes com média de idade de 71,1 ± 10,5 anos ao longo de um período de tratamento de 237,6 pacientes-ano. A mediana do escore HAS-BLED foi de 2 (1-3). A incidência de sangramento maior foi de 5,7%, sendo mais elevada nos pacientes de alto risco que nos pacientes de baixo risco (9,6 vs. 3,1%; p = 0,052). A área sob a curva ROC foi de 0,70 (p = 0,01). Um ponto de corte ≥ 3 mostrou sensibilidade de 66,7%, especificidade de 62,1%, valor preditivo positivo de 9,6% e valor preditivo negativo de 96,9%. Sobrevida livre de sangramento maior foi menor no grupo de alto risco (p = 0,017). Na análise multivariada, o único preditor independente de sangramento maior entre os componentes do escore foi o uso concomitante de antiplaquetários (OR 5,13, IC95%: 1,55-17,0; p = 0,007). Conclusão: O escore HAS-BLED foi capaz de prever sangramento maior na população de pacientes com FA estudada. Entre os componentes do escore, atenção especial deve ser dada para o uso concomitante de antiplaquetários, que mostrou associação independente. Em pacientes com FA em uso de AVK como terapia anticoagulante, o uso de antiplaquetários deve ser realizado somente naqueles pacientes com avaliação risco-benefício favorável


Background: HAS-BLED s core was developed to assess 1-year major bleeding risk in patients anticoagulated with vitamin K antagonists (VKA) due to atrial fibrillation (AF). Objective: Of this study was to assess the ability of HAS-BLED score and its components to predict major bleeding in patients treated in an anticoagulation outpatient clinic of a tertiary hospital. Methods: A retrospective cohort study on AF patients treated with VKA was conducted. Logistic regression analysis was performed to evaluate the ability of individual score components to predict major bleeding. The significance level adopted in all tests was 5%. Results: We studied 263 patients with a mean age of 71.1 ± 10.5 years over a period of 237.6 patients-year. Median HAS-BLED score was 2 (1-3). The overall incidence of major bleeding was 5.7%, and it was higher among high-risk HAS-BLED score patients than in low risk patients (9.6 vs. 3.1%; p = 0.052). Area under the ROC curve was 0.70 (p = 0.01). Cut-off point ≥ 3 showed sensibility of 66.7%, specificity of 62.1%, positive predictive value of 9.6% and negative predictive value of 96.9%. Major bleeding-free survival was lower in high-risk group (p = 0.017). In multivariate analysis, concurrent antiplatelet use was the only independent predictor of major bleeding among score components (OR 5.13, 95%CI: 1.55-17.0; p = 0.007). Conclusion: HAS-BLED score was able to predict major bleeding in this cohort of AF patients. Among score components, special attention should be given for concomitant antiplatelet use, which was independently associated to this outcome. Antiplatelets in AF patients under VKA anticoagulation should be used in selected patients with favorable risk-benefit assessment


Assuntos
Humanos , Masculino , Feminino , Anticoagulantes/uso terapêutico , Hemorragia/complicações , Ambulatório Hospitalar , Centros de Atenção Terciária , Fibrilação Atrial/fisiopatologia , Doenças Cardiovasculares/fisiopatologia , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco , Curva ROC , Análise Estatística , Acidente Vascular Cerebral/complicações , Vitamina K
7.
Rev. bras. cir. cardiovasc ; 32(5): 372-377, Sept.-Oct. 2017. tab, graf
Artigo em Inglês | LILACS-Express | ID: biblio-897947

RESUMO

Abstract Introduction: The outcomes of Jehovah's Witness (JW) patients submitted to open heart surgery may vary across countries and communities. The aim of this study was to describe the morbidity and mortality of JW patients undergoing cardiac surgery in a tertiary hospital center in Southern Brazil. Methods: A case-control study was conducted including all JW patients submitted to cardiac surgery from 2008 to 2016. Three consecutive surgical non-JW controls were matched to each selected JW patient. The preoperative risk of death was estimated through the mean EuroSCORE II. Results: We studied 16 JW patients with a mean age of 60.6±12.1 years. The non-JW group included 48 patients with a mean age of 63.3±11.1 years (P=0.416). Isolated coronary artery bypass graft surgery was the most frequent surgery performed in both groups. Median EuroSCORE II was 1.29 (IQR: 0.66-3.08) and 1.43 (IQR: 0.72-2.63), respectively (P=0.988). The mortality tended to be higher in JW patients (18.8% vs. 4.2%, P=0.095), and there was a higher difference between the predicted and observed mortality in JW patients compared with controls (4.1 and 18.8% vs. 2.1 and 4.2%). More JW patients needed hemodialysis in the postoperative period (20.0 vs. 2.1%, P=0.039). Conclusion: We showed a high rate of in-hospital mortality in JW patients submitted to cardiac surgery. The EuroSCORE II may underestimate the surgical risk in these patients.

9.
Clin Case Rep ; 5(7): 1176-1180, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28680621

RESUMO

Syncopal spells in heart failure patient with cardiovascular implantable electronic devices (CIED) require multiple assessments. T-wave oversensing is a well-described phenomenon that remains significant in modern implantable cardioverter defibrillators (ICD) systems. It can lead to inappropriate therapies and loss of biventricular pacing in those with cardiac resynchronization devices. Strategies to overcome this problem are important.

10.
Braz. j. infect. dis ; 21(3): 349-352, May-June 2017. graf
Artigo em Inglês | LILACS-Express | ID: biblio-839210

RESUMO

ABSTRACT In the antibiotic era, aortic aneurysm is a rare complication of syphilis, what makes the diagnostic assumption even more difficult. Nonetheless, this condition should be suspected in patients with aortic aneurysm. Reports of aortic dissection complicating syphilitic aortitis have been distinctly rare in the literature, and their cause-effect relationship has not been definitely established. In this case report, we present a 62-year-old woman with aortic aneurysm and dissection associated with an unexpected diagnosis of syphilitic aortitis.

11.
Arq Bras Cardiol ; 108(4): 290-296, 2017 04.
Artigo em Inglês, Português | MEDLINE | ID: mdl-28538758

RESUMO

Background: The SAMe-TT2R2 score was developed to predict which patients on oral anticoagulation with vitamin K antagonists (VKAs) will reach an adequate time in therapeutic range (TTR) (> 65%-70%). Studies have reported a relationship between this score and the occurrence of adverse events. Objective: To describe the TTR according to the score, in addition to relating the score obtained with the occurrence of adverse events in patients with nonvalvular atrial fibrillation (AF) on oral anticoagulation with VKAs. Methods: Retrospective cohort study including patients with nonvalvular AF attending an outpatient anticoagulation clinic of a tertiary hospital. Visits to the outpatient clinic and emergency, as well as hospital admissions to the institution, during 2014 were evaluated. The TTR was calculated through the Rosendaal´s method. Results: We analyzed 263 patients (median TTR, 62.5%). The low-risk group (score 0-1) had a better median TTR as compared with the high-risk group (score ≥ 2): 69.2% vs. 56.3%, p = 0.002. Similarly, the percentage of patients with TTR ≥ 60%, 65% or 70% was higher in the low-risk group (p < 0.001, p = 0.001 and p = 0.003, respectively). The high-risk group had a higher percentage of adverse events (11.2% vs. 7.2%), although not significant (p = 0.369). Conclusions: The SAMe-TT2R2 score proved to be effective to predict patients with a better TTR, but was not associated with adverse events. Fundamento: O escore SAMe-TT2R2 foi desenvolvido visando predizer quais pacientes em anticoagulação oral com antagonistas da vitamina K (AVKs) atingirão um tempo na faixa terapêutica (TFT) adequado (> 65%-70%) no seguimento. Estudos também o relacionaram com a ocorrência de eventos adversos. Objetivos: Descrever o TFT de acordo com o escore, além de relacionar a pontuação obtida com a ocorrência de eventos adversos adversos em pacientes com fibrilação atrial (FA) não valvar em anticoagulação oral com AVKs. Métodos: Estudo de coorte retrospectivo incluindo pacientes com FA não valvar em acompanhamento em ambulatório de anticoagulação de um hospital terciário. Foi realizada uma avaliação retrospectiva de consultas ambulatoriais, visitas a emergência e internações hospitalares na instituição no período de janeiro-dezembro/2014. O TFT foi calculado aplicando-se o método de Rosendaal. Resultados: Foram analisados 263 pacientes com TFT mediano de 62,5%. O grupo de baixo risco (0-1 ponto) obteve um TFT mediano maior em comparação com o grupo de alto risco (≥ 2 pontos): 69,2% vs. 56,3%, p = 0,002. Da mesma forma, o percentual de pacientes com TFT ≥ 60%, 65% ou 70% foi superior nos pacientes de baixo risco (p < 0,001, p = 0,001 e p = 0,003, respectivamente). Os pacientes de alto risco tiveram um percentual maior de eventos adversos (11,2% vs. 7,2%), embora não significativo (p = 0,369). Conclusões: O escore SAMe-TT2R2 foi uma ferramenta eficaz na predição do TFT em pacientes com FA em uso de AVKs para anticoagulação, porém não se associou à ocorrência de eventos adversos.


Assuntos
Anticoagulantes/uso terapêutico , Fibrilação Atrial/complicações , Hemorragia/induzido quimicamente , Acidente Vascular Cerebral/prevenção & controle , Tromboembolia/prevenção & controle , Vitamina K/antagonistas & inibidores , Varfarina/uso terapêutico , Idoso , Anticoagulantes/efeitos adversos , Técnicas de Apoio para a Decisão , Intervalo Livre de Doença , Feminino , Humanos , Coeficiente Internacional Normatizado , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Tempo de Protrombina , Estudos Retrospectivos , Índice de Gravidade de Doença , Acidente Vascular Cerebral/etiologia , Tromboembolia/etiologia , Varfarina/efeitos adversos
13.
Arq. bras. cardiol ; 108(4): 290-296, Apr. 2017. tab, graf
Artigo em Inglês | LILACS-Express | ID: biblio-838729

RESUMO

Abstract Background: The SAMe-TT2R2 score was developed to predict which patients on oral anticoagulation with vitamin K antagonists (VKAs) will reach an adequate time in therapeutic range (TTR) (> 65%-70%). Studies have reported a relationship between this score and the occurrence of adverse events. Objective: To describe the TTR according to the score, in addition to relating the score obtained with the occurrence of adverse events in patients with nonvalvular atrial fibrillation (AF) on oral anticoagulation with VKAs. Methods: Retrospective cohort study including patients with nonvalvular AF attending an outpatient anticoagulation clinic of a tertiary hospital. Visits to the outpatient clinic and emergency, as well as hospital admissions to the institution, during 2014 were evaluated. The TTR was calculated through the Rosendaal´s method. Results: We analyzed 263 patients (median TTR, 62.5%). The low-risk group (score 0-1) had a better median TTR as compared with the high-risk group (score ≥ 2): 69.2% vs. 56.3%, p = 0.002. Similarly, the percentage of patients with TTR ≥ 60%, 65% or 70% was higher in the low-risk group (p < 0.001, p = 0.001 and p = 0.003, respectively). The high-risk group had a higher percentage of adverse events (11.2% vs. 7.2%), although not significant (p = 0.369). Conclusions: The SAMe-TT2R2 score proved to be effective to predict patients with a better TTR, but was not associated with adverse events.


Resumo Fundamento: O escore SAMe-TT2R2 foi desenvolvido visando predizer quais pacientes em anticoagulação oral com antagonistas da vitamina K (AVKs) atingirão um tempo na faixa terapêutica (TFT) adequado (> 65%-70%) no seguimento. Estudos também o relacionaram com a ocorrência de eventos adversos. Objetivos: Descrever o TFT de acordo com o escore, além de relacionar a pontuação obtida com a ocorrência de eventos adversos adversos em pacientes com fibrilação atrial (FA) não valvar em anticoagulação oral com AVKs. Métodos: Estudo de coorte retrospectivo incluindo pacientes com FA não valvar em acompanhamento em ambulatório de anticoagulação de um hospital terciário. Foi realizada uma avaliação retrospectiva de consultas ambulatoriais, visitas a emergência e internações hospitalares na instituição no período de janeiro-dezembro/2014. O TFT foi calculado aplicando-se o método de Rosendaal. Resultados: Foram analisados 263 pacientes com TFT mediano de 62,5%. O grupo de baixo risco (0-1 ponto) obteve um TFT mediano maior em comparação com o grupo de alto risco (≥ 2 pontos): 69,2% vs. 56,3%, p = 0,002. Da mesma forma, o percentual de pacientes com TFT ≥ 60%, 65% ou 70% foi superior nos pacientes de baixo risco (p < 0,001, p = 0,001 e p = 0,003, respectivamente). Os pacientes de alto risco tiveram um percentual maior de eventos adversos (11,2% vs. 7,2%), embora não significativo (p = 0,369). Conclusões: O escore SAMe-TT2R2 foi uma ferramenta eficaz na predição do TFT em pacientes com FA em uso de AVKs para anticoagulação, porém não se associou à ocorrência de eventos adversos.

14.
Braz J Infect Dis ; 21(3): 349-352, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28238625

RESUMO

In the antibiotic era, aortic aneurysm is a rare complication of syphilis, what makes the diagnostic assumption even more difficult. Nonetheless, this condition should be suspected in patients with aortic aneurysm. Reports of aortic dissection complicating syphilitic aortitis have been distinctly rare in the literature, and their cause-effect relationship has not been definitely established. In this case report, we present a 62-year-old woman with aortic aneurysm and dissection associated with an unexpected diagnosis of syphilitic aortitis.


Assuntos
Aneurisma Aórtico/diagnóstico , Sífilis Cardiovascular/diagnóstico , Feminino , Humanos , Pessoa de Meia-Idade
18.
Clin. biomed. res ; 37(1): 51-54, 2017. ilus
Artigo em Português | LILACS | ID: biblio-833304

RESUMO

A miocardite é cada vez mais diagnosticada, principalmente pela maior disponibilidade de métodos como a ressonância magnética cardíaca. A apresentação clínica é variável, geralmente posterior a uma infecção respiratória ou gastrointestinal, manifestando-se como síndrome coronariana aguda (SCA), insuficiência cardíaca aguda ou crônica, arritmias cardíacas ou mesmo choque cardiogênico inexplicável. Relatos de casos de miocardite após infecção do trato urinário (ITU) são escassos. Neste relato, descrevemos o caso de um paciente masculino de 24 anos com miocardite após ITU que se apresentou sob a forma de SCA(AU)


The diagnosis of myocarditis has increased mainly due to greater availability of methods such as cardiac magnetic resonance (CMR). Its clinical presentation varies, usually following respiratory or gastrointestinal tract infection, in patients presenting with acute coronary syndrome (ACS), acute or chronic heart failure, cardiac arrhythmias, or even unexplained cardiogenic shock. Case reports of patients with myocarditis following urinary tract infection (UTI) are scarce. This is a case report of a 24-year-old male patient with myocarditis with symptoms of ACS following UTI(AU)


Assuntos
Humanos , Masculino , Adulto , Síndrome Coronariana Aguda/diagnóstico , Miocardite/diagnóstico , Miocardite/tratamento farmacológico , Miocardite/etiologia , Infecções Urinárias/complicações , Diagnóstico Diferencial
19.
Clin. biomed. res ; 37(4): 358-361, 2017. ilus
Artigo em Inglês | LILACS | ID: biblio-877330

RESUMO

Left ventricular noncompaction (LVNC) is a rare form of cardiomyopathy characterized by prominent left ventricular (LV) trabeculae, deep intertrabecular recesses, and the thin compacted layer. The disease is potentially associated with sudden cardiac death due to LV dysfunction and ventricular arrhythmias. The presence of accessory pathway and Wolff-Parkinson-White syndrome is particularly rare in adults. Here we describe the rare association of LVNC and ventricular pre-excitation in an 18-year-old female with neonatal hypoxic brain injury (AU)


Assuntos
Humanos , Feminino , Adolescente , Miocárdio Ventricular não Compactado Isolado/diagnóstico , Síndrome de Wolff-Parkinson-White/diagnóstico , Cardiomiopatias/diagnóstico , Cardiopatias/diagnóstico , Ventrículos do Coração/fisiopatologia , Miocárdio Ventricular não Compactado Isolado/fisiopatologia
20.
Rev. bras. cardiol. invasiva ; 24(1-4): f:4-l:8, jan.-dez. 2016. tab, graf
Artigo em Português | LILACS | ID: biblio-878920

RESUMO

Introdução: Existem poucos dados nacionais a respeito dos resultados da intervenção coronária percutânea (ICP) primária, e os registros são uma ótima ferramenta para a avaliação do perfil dos pacientes e dos desfechos pós-procedimento. O objetivo deste estudo foi descrever o perfil dos pacientes com ICP primária em um hospital geral terciário, bem como avaliar os desfechos cardiovasculares hospitalares e em 30 dias. Métodos: Foram incluídos todos os pacientes submetidos à ICP primária entre 2012 a 2015. Trata-se de um registro prospectivo, no qual os desfechos clínicos analisados foram a ocorrência de morte, infarto ou acidente vascular cerebral, e eventos cardiovasculares e cerebrovasculares maiores (ECCAM). Resultados: Foram incluídos 323 pacientes, com idade 60 ± 12 anos, sendo 66,7% do sexo masculino, 28,5% diabéticos. Na admissão, 13,5% dos pacientes apresentavam-se em Killip III/IV. O tempo dor-porta foi de 4,4 ± 2,5 horas e o tempo porta-balão foi 68,0 ± 34,0 minutos. A mortalidade hospitalar foi de 9,9%, e 18,3% dos pacientes apresentaram ECCAM em 30 dias. Conclusões: Os pacientes submetidos à ICP primária apresentaram taxas elevadas de ECCAM, que podem ser atribuídas à apresentação clínica mais grave e a um longo tempo de isquemia. Um atendimento mais rápido destes pacientes, variável modificável, demanda uma atenção imediata do sistema de saúde


Background: There are few national data on the results of primary percutaneous coronary intervention (PCI), and registries are a great tool for assessing patient profiles and post-procedure outcomes. The aim of this study was to describe the profile of patients with primary PCI in a general tertiary hospital, as well as to evaluate in-hospital and 30-day cardiovascular outcomes. Methods: The study included all patients submitted to primary PCI between 2012 and 2015. This was a prospective registry, in which the analyzed clinical outcomes were the occurrence of death, infarction, or stroke, and major cardiovascular and cerebrovascular events (MACCE). Results: The study included 323 patients, aged 60 ± 12 years, of whom 66.7% were males, 28.5% diabetics. At admission, 13.5% of the patients were classified as Killip class III/IV. The pain-to-door time was 4.4 ± 2.5 hours and the door-to-balloon time was 68.0 ± 34.0 minutes. Hospital mortality was 9.9%, and 18.3% of the patients presented MACCE in 30 days. Conclusions: Patients submitted to primary PCI had high rates of MACCE, which can be attributed to the more severe clinical presentation and to a long time of ischemia. The faster treatment of these patients, a modifiable variable, demands immediate attention from the health system


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Doenças Cardiovasculares , Intervenção Coronária Percutânea/métodos , Centros de Atenção Terciária , Resultado do Tratamento , Síndrome Coronariana Aguda , Angioplastia/métodos , Artéria Femoral , Infarto do Miocárdio/mortalidade , Isquemia Miocárdica/mortalidade , Estudos Prospectivos , Artéria Radial , Fatores de Risco , Análise Estatística , Volume Sistólico , Trombectomia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA